Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. / Palmerini, Tullio; Serruys, Patrick W.; Kappetein, Arie Pieter et al.
I: American Heart Journal, Bind 190, 01.08.2017, s. 54-63.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Palmerini, T, Serruys, PW, Kappetein, AP, Genereux, P, Riva, DD, Reggiani, LB, Christiansen, E, Holm, NR, Thuesen, L, Makikallio, T, Morice, M-C, Ahn, JM, Park, S-J, Thiele, H, Boudriot, E, Sabatino, M, Romanello, M, Biondi-Zoccai, GGL, Cavalcante, R, Sabik, JF & Stone, GW 2017, 'Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients', American Heart Journal, bind 190, s. 54-63. https://doi.org/10.1016/j.ahj.2017.05.005

APA

Palmerini, T., Serruys, P. W., Kappetein, A. P., Genereux, P., Riva, D. D., Reggiani, L. B., Christiansen, E., Holm, N. R., Thuesen, L., Makikallio, T., Morice, M-C., Ahn, J. M., Park, S-J., Thiele, H., Boudriot, E., Sabatino, M., Romanello, M., Biondi-Zoccai, G. G. L., Cavalcante, R., ... Stone, G. W. (2017). Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. American Heart Journal, 190, 54-63. https://doi.org/10.1016/j.ahj.2017.05.005

CBE

MLA

Vancouver

Palmerini T, Serruys PW, Kappetein AP, Genereux P, Riva DD, Reggiani LB et al. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. American Heart Journal. 2017 aug. 1;190:54-63. doi: 10.1016/j.ahj.2017.05.005

Author

Bibtex

@article{3239447c443742948d33349133ec64dc,
title = "Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients",
abstract = "Some but not all randomized controlled trials (RCT) have suggested that percutaneous coronary intervention (PCI) with drug-eluting stents may be an acceptable alternative to coronary artery bypass grafting (CABG) surgery for the treatment of unprotected left main coronary artery disease (ULMCAD). We therefore aimed to compare the risk of all-cause mortality between PCI and CABG in patients with ULMCAD in a pairwise meta-analysis of RCT. Methods Randomized controlled trials comparing PCI vs CABG for the treatment of ULMCAD were searched through MEDLINE, EMBASE, Cochrane databases, and proceedings of international meetings. Results Six trials including 4,686 randomized patients were identified. After a median follow-up of 39 months, there were no significant differences between PCI vs CABG in the risk of all-cause mortality (hazard ratio [HR] 0.99, 95% CI 0.76-1.30) or cardiac mortality. However, a significant interaction for cardiac mortality (Pinteraction=.03) was apparent between randomization arm and SYNTAX score, such that the relative risk for mortality tended to be lower with PCI compared with CABG among patients in the lower SYNTAX score tertile, similar in the intermediate tertile, and higher in the upper SYNTAX score tertile. Percutaneous coronary intervention compared with CABG was associated with a similar long-term composite risk of death, myocardial infarction, or stroke (HR 1.06, 95% CI 0.82-1.37), with fewer events within 30 days after PCI offset by fewer events after 30 days with CABG (Pinteraction <.0001). Percutaneous coronary intervention was associated with greater rates of unplanned revascularization compared with CABG (HR 1.74, 95% CI 1.47-2.07). Conclusions In patients undergoing revascularization for ULMCAD, PCI was associated with similar rates of mortality compared with CABG at a median follow-up of 39 months, but with an interaction effect suggesting relatively lower mortality with PCI in patients with low SYNTAX score and relatively lower mortality with CABG in patients with high SYNTAX score. Both procedures resulted in similar long-term composite rates of death, myocardial infarction, or stroke, with PCI offering an early safety advantage and CABG demonstrating greater durability.",
author = "Tullio Palmerini and Serruys, {Patrick W.} and Kappetein, {Arie Pieter} and Philippe Genereux and Riva, {Diego Della} and Reggiani, {Letizia Bacchi} and Evald Christiansen and Holm, {Niels R.} and Leif Thuesen and Timo Makikallio and Marie-Claude Morice and Ahn, {Jung Min} and Seung-Jung Park and Holger Thiele and Enno Boudriot and Mario Sabatino and Mattia Romanello and Biondi-Zoccai, {Giuseppe G L} and Raphael Cavalcante and Sabik, {Joseph F.} and Stone, {Gregg W}",
year = "2017",
month = aug,
day = "1",
doi = "10.1016/j.ahj.2017.05.005",
language = "English",
volume = "190",
pages = "54--63",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby, Inc",

}

RIS

TY - JOUR

T1 - Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease

T2 - A meta-analysis of 6 randomized trials and 4,686 patients

AU - Palmerini, Tullio

AU - Serruys, Patrick W.

AU - Kappetein, Arie Pieter

AU - Genereux, Philippe

AU - Riva, Diego Della

AU - Reggiani, Letizia Bacchi

AU - Christiansen, Evald

AU - Holm, Niels R.

AU - Thuesen, Leif

AU - Makikallio, Timo

AU - Morice, Marie-Claude

AU - Ahn, Jung Min

AU - Park, Seung-Jung

AU - Thiele, Holger

AU - Boudriot, Enno

AU - Sabatino, Mario

AU - Romanello, Mattia

AU - Biondi-Zoccai, Giuseppe G L

AU - Cavalcante, Raphael

AU - Sabik, Joseph F.

AU - Stone, Gregg W

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Some but not all randomized controlled trials (RCT) have suggested that percutaneous coronary intervention (PCI) with drug-eluting stents may be an acceptable alternative to coronary artery bypass grafting (CABG) surgery for the treatment of unprotected left main coronary artery disease (ULMCAD). We therefore aimed to compare the risk of all-cause mortality between PCI and CABG in patients with ULMCAD in a pairwise meta-analysis of RCT. Methods Randomized controlled trials comparing PCI vs CABG for the treatment of ULMCAD were searched through MEDLINE, EMBASE, Cochrane databases, and proceedings of international meetings. Results Six trials including 4,686 randomized patients were identified. After a median follow-up of 39 months, there were no significant differences between PCI vs CABG in the risk of all-cause mortality (hazard ratio [HR] 0.99, 95% CI 0.76-1.30) or cardiac mortality. However, a significant interaction for cardiac mortality (Pinteraction=.03) was apparent between randomization arm and SYNTAX score, such that the relative risk for mortality tended to be lower with PCI compared with CABG among patients in the lower SYNTAX score tertile, similar in the intermediate tertile, and higher in the upper SYNTAX score tertile. Percutaneous coronary intervention compared with CABG was associated with a similar long-term composite risk of death, myocardial infarction, or stroke (HR 1.06, 95% CI 0.82-1.37), with fewer events within 30 days after PCI offset by fewer events after 30 days with CABG (Pinteraction <.0001). Percutaneous coronary intervention was associated with greater rates of unplanned revascularization compared with CABG (HR 1.74, 95% CI 1.47-2.07). Conclusions In patients undergoing revascularization for ULMCAD, PCI was associated with similar rates of mortality compared with CABG at a median follow-up of 39 months, but with an interaction effect suggesting relatively lower mortality with PCI in patients with low SYNTAX score and relatively lower mortality with CABG in patients with high SYNTAX score. Both procedures resulted in similar long-term composite rates of death, myocardial infarction, or stroke, with PCI offering an early safety advantage and CABG demonstrating greater durability.

AB - Some but not all randomized controlled trials (RCT) have suggested that percutaneous coronary intervention (PCI) with drug-eluting stents may be an acceptable alternative to coronary artery bypass grafting (CABG) surgery for the treatment of unprotected left main coronary artery disease (ULMCAD). We therefore aimed to compare the risk of all-cause mortality between PCI and CABG in patients with ULMCAD in a pairwise meta-analysis of RCT. Methods Randomized controlled trials comparing PCI vs CABG for the treatment of ULMCAD were searched through MEDLINE, EMBASE, Cochrane databases, and proceedings of international meetings. Results Six trials including 4,686 randomized patients were identified. After a median follow-up of 39 months, there were no significant differences between PCI vs CABG in the risk of all-cause mortality (hazard ratio [HR] 0.99, 95% CI 0.76-1.30) or cardiac mortality. However, a significant interaction for cardiac mortality (Pinteraction=.03) was apparent between randomization arm and SYNTAX score, such that the relative risk for mortality tended to be lower with PCI compared with CABG among patients in the lower SYNTAX score tertile, similar in the intermediate tertile, and higher in the upper SYNTAX score tertile. Percutaneous coronary intervention compared with CABG was associated with a similar long-term composite risk of death, myocardial infarction, or stroke (HR 1.06, 95% CI 0.82-1.37), with fewer events within 30 days after PCI offset by fewer events after 30 days with CABG (Pinteraction <.0001). Percutaneous coronary intervention was associated with greater rates of unplanned revascularization compared with CABG (HR 1.74, 95% CI 1.47-2.07). Conclusions In patients undergoing revascularization for ULMCAD, PCI was associated with similar rates of mortality compared with CABG at a median follow-up of 39 months, but with an interaction effect suggesting relatively lower mortality with PCI in patients with low SYNTAX score and relatively lower mortality with CABG in patients with high SYNTAX score. Both procedures resulted in similar long-term composite rates of death, myocardial infarction, or stroke, with PCI offering an early safety advantage and CABG demonstrating greater durability.

UR - http://www.scopus.com/inward/record.url?scp=85020011675&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2017.05.005

DO - 10.1016/j.ahj.2017.05.005

M3 - Journal article

C2 - 28760214

AN - SCOPUS:85020011675

VL - 190

SP - 54

EP - 63

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

ER -